Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series. Fricke J, Wang J, Gallego N, Mambetsariev I, et al. Clin Lung Cancer 2023;24:666-671.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fricke J, Wang J, Gallego N, Mambetsariev I, et al. Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case Series. Clin Lung Cancer 2023;24:666-671.
PMID: 37580188